Abnormally High Metabolism In An Area Of The Brain May Account For Many Symptoms Of Depression, Say Pitt Researchers

October 28, 1997

PITTSBURGH, Oct. 28 -- Using positron emission tomography and magnetic resonance imaging, researchers at UPMC Health System have found evidence that many emotional symptoms of depression may be caused by abnormally high metabolism in an almond-sized area in the center of the brain called the amygdala (pronounced a-mig da-la).

This finding, reported today at the 1997 Society for Neuroscience Annual Meeting in New Orleans, may lead to greater understanding of how antidepressant and mood stabilizing treatments work and eventually to more effective treatments for depression and bipolar disorder, which together affect nearly 19 million people in the United States.

Wayne Drevets, M.D., associate professor of psychiatry and radiology at the UPMC, explained that by superimposing PET images, which tend to be blurry, over crisp pictures obtained with MRI, they were able to further study the brain structure implicated earlier this year as holding a key role in the development of depression. The technology also enabled them to demonstrate for the first time that depressed people with bipolar disorder, also known as manic-depressive illness, have abnormally high glucose metabolism in this area as well.

The study involved PET images of glucose metabolism and MRI images of brain structure in 32 subjects with major depressive disorder or bipolar disorder and 15 healthy controls who had never had a major depressive episode.

"Antidepressant drug treatment, which is effective at both improving and preventing depressive episodes, reduces amygdala metabolism," explained Dr. Drevets. "What we now know suggests that if we can develop drugs that more effectively reduce metabolism in this structure, we may be able to better treat or prevent depression as well as mania."

Abnormal metabolism in the amygdala is central to many of the symptoms of depression because of the structure's importance in mediating emotional processing. The amygdala helps the brain learn the emotional significance of sensory signals, such as situations that present a threat, and organize the way those signals are expressed, from rapid heart beat to facial expressions. Because of its key role in producing such things as fear, dysphoria and sometimes vivid recall of past emotionally charged events, abnormal activity in this small section of the brain may be responsible for the development of anxiety, panic attacks and many symptoms of depression, continued Dr. Drevets.

The Pitt researchers are now studying why the amygdala has abnormally high metabolism and how this metabolism affects the structure itself. New studies will show the functioning of the amygdala as subjects perform tasks, demonstrate the function of the chemical receptors that control amygdala activity and assess the changes in these measures during antidepressant treatment.

"We hope our continuing research will ultimately lead to a clearer understanding of major depression and mania and to more effective treatments," concluded Dr. Drevets.

For additional information about UPMC Health System, please access http://www.upmc.edu.

University of Pittsburgh Medical Center

Related Depression Articles from Brightsurf:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.

Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.

Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.

Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.

Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.

Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.

Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.

CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.

Read More: Depression News and Depression Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.